Atossa Therapeutics Inc (ATOS)
1.415
+0.06
(+4.81%)
USD |
NASDAQ |
Apr 18, 16:00
1.415
0.00 (0.00%)
After-Hours: 17:28
Atossa Therapeutics Free Cash Flow (Quarterly): -5.571M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.571M |
| September 30, 2023 | -3.884M |
| June 30, 2023 | -4.478M |
| March 31, 2023 | -7.022M |
| December 31, 2022 | -4.531M |
| September 30, 2022 | -5.416M |
| June 30, 2022 | -5.949M |
| March 31, 2022 | -4.891M |
| December 31, 2021 | -3.665M |
| September 30, 2021 | -3.071M |
| June 30, 2021 | -5.337M |
| March 31, 2021 | -4.408M |
| December 31, 2020 | -3.432M |
| September 30, 2020 | -2.681M |
| June 30, 2020 | -2.236M |
| March 31, 2020 | -3.23M |
| December 31, 2019 | -2.708M |
| September 30, 2019 | -1.769M |
| June 30, 2019 | -2.510M |
| March 31, 2019 | -2.149M |
| December 31, 2018 | -2.500M |
| September 30, 2018 | -2.301M |
| June 30, 2018 | -1.833M |
| March 31, 2018 | -2.438M |
| December 31, 2017 | -1.683M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.702M |
| June 30, 2017 | -1.349M |
| March 31, 2017 | -1.861M |
| December 31, 2016 | -1.360M |
| September 30, 2016 | 0.6354M |
| June 30, 2016 | -1.659M |
| March 31, 2016 | -3.000M |
| December 31, 2015 | -4.017M |
| September 30, 2015 | -3.532M |
| June 30, 2015 | -3.508M |
| March 31, 2015 | -3.027M |
| December 31, 2014 | -2.595M |
| September 30, 2014 | -3.074M |
| June 30, 2014 | -2.342M |
| March 31, 2014 | -2.707M |
| December 31, 2013 | -2.737M |
| September 30, 2013 | -3.049M |
| June 30, 2013 | -2.191M |
| March 31, 2013 | -1.343M |
| December 31, 2012 | -1.932M |
| September 30, 2012 | -0.151M |
| June 30, 2012 | -0.8115M |
| March 31, 2012 | -1.005M |
| December 31, 2011 | -1.090M |
| September 30, 2011 | -1.360M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-7.022M
Minimum
Mar 2023
-1.769M
Maximum
Sep 2019
-4.042M
Average
-3.884M
Median
Sep 2023
Free Cash Flow (Quarterly) Benchmarks
| AngioDynamics Inc | -16.38M |
| Biolase Inc | -2.468M |
| Outset Medical Inc | -25.50M |
| Perspective Therapeutics Inc | -9.097M |
| Electromed Inc | 3.384M |